Nagler A, Labopin M, Swoboda R, Kulagin A, et al. Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplant 2023 May 30. doi: 10.1038/s41409-023-02012.
PMID: 37253804